Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose? (Q34296600)

1 August 2017

title

Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose? (English)

1 reference

1 August 2017

0 references

Bernard Bannwarth

1 reference

1 August 2017

publication date

1 September 2012

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

1713-1723

1 reference

Facing up to the prescription opioid crisis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Responsible prescribing of opioids for the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

A difficult balance--pain management, drug safety, and the FDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

A flood of opioids, a rising tide of deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Opioid prescriptions for chronic pain and overdose: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Patterns of abuse among unintentional pharmaceutical overdose fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Challenges in the development of prescription opioid abuse-deterrent formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Prescription drug addiction: the treatment challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Should we be reluctant to prescribe opioids for chronic non-malignant pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Issues in long-term opioid therapy: unmet needs, risks, and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

An analysis of the root causes for opioid-related overdose deaths in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Scientists probe ways to curb opioid abuse without hindering pain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Can prescription drug monitoring programs help limit opioid abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Opioid formulations designed to resist/deter abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11635860-000000000-00000

Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

21 January 2018

1 reference

12 December 2020

Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain

1 reference

12 December 2020

Current approaches in tamper-resistant and abuse-deterrent formulations

1 reference

12 December 2020

Opioids for chronic pain

1 reference

12 December 2020

Opioid formulations in development designed to curtail abuse: who is the target?

1 reference

12 December 2020

Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective

1 reference

12 December 2020

Effect of Abuse-Deterrent Formulation of OxyContin

1 reference

12 December 2020

Irrelevance of the WHO analgesic ladder for managing rheumatic pain

1 reference

12 December 2020

Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

1 reference

12 December 2020

Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008.

1 reference

12 December 2020

10.2165/11635860-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1040756595

0 references

1 reference